Who owns CONDUIT PHARMACEUTICALS INC?
- Ticker: CDT
- CUSIP Number: 20678x106
Tip: Access positions for across all investors
Analyze quarterly positions in Conduit Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Conduit Pharmaceuticals stock
Who bought or sold CONDUIT PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Barclays | 804k | $3.0M | 0% | Mar 2024 |
|
| Vanguard Group | 208k | $763k | -12% | Mar 2024 |
|
| BlackRock | 172k | $630k | 100% | Mar 2024 |
|
| Geode Capital Management | 139k | $510k | 100% | Mar 2024 |
|
| Goldman Sachs Group | 69k | $252k | 100% | Mar 2024 |
|
| Marshall Wace | 62k | $227k | 100% | Mar 2024 |
|
| Qube Research & Technologies | 41k | $150k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 27k | $99k | 318% | Mar 2024 |
|
| Northern Trust | 22k | $80k | 100% | Mar 2024 |
|
| Y-Intercept | 19k | $71k | 100% | Mar 2024 |
|
| Morgan Stanley | 12k | $43k | 47048% | Mar 2024 |
|
| Bank Of Montreal | 10k | $38k | 0% | Mar 2024 |
|
| Bank of America Corporation | 8.0k | $29k | 1337% | Mar 2024 |
|
| Tower Research Capital | 3.9k | $14k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 75.00 | $275.002500 | 4% | Mar 2024 |
|
| UBS Group | 41.00 | $150.703700 | 100% | Mar 2024 |
|
Who sold out of Conduit Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2023 | 17k | $75k |